Artikel mit Open-Access-Mandaten - Paul DeclerckWeitere Informationen
Nicht verfügbar: 21
Harmonization of infliximab and anti-infliximab assays facilitates the comparison between originators and biosimilars in clinical samples
A Gils, T Van Stappen, E Dreesen, R Storme, S Vermeire, PJ Declerck
Inflammatory bowel diseases 22 (4), 969-975, 2016
Mandate: Research Foundation (Flanders)
Biosimilars: controversies as illustrated by rhGH
PJ Declerck, F Darendeliler, M Goth, S Kolouskova, I Micle, C Noordam, ...
Current medical research and opinion 26 (5), 1219-1229, 2010
Mandate: Hungarian Scientific Research Fund
Generation of a highly specific monoclonal anti-infliximab antibody for harmonization of TNF-coated infliximab assays
T Van Stappen, E Brouwers, S Tops, N Geukens, S Vermeire, PJ Declerck, ...
Therapeutic drug monitoring 37 (4), 479-485, 2015
Mandate: Research Foundation (Flanders)
Identification and characterisation of monoclonal antibodies that impair the activation of human thrombin activatable fibrinolysis inhibitor through different mechanisms
N Mishra, E Vercauteren, J Develter, R Bammens, PJ Declerck, A Gils
Thrombosis and haemostasis 106 (07), 90-101, 2011
Mandate: Research Foundation (Flanders)
Active PAI-1 as marker for venous thromboembolism: Case–control study using a comprehensive panel of PAI-1 and TAFI assays
L Bollen, M Peetermans, M Peeters, K Van Steen, MF Hoylaerts, ...
Thrombosis research 134 (5), 1097-1102, 2014
Mandate: Research Foundation (Flanders)
Plant pectin methylesterase and its inhibitor from kiwi fruit: Interaction analysis by surface plasmon resonance
RP Jolie, T Duvetter, K Houben, E Vandevenne, AM Van Loey, ...
Food Chemistry 121 (1), 207-214, 2010
Mandate: Research Foundation (Flanders)
Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1
B Van De Craen, I Scroyen, C Vranckx, G Compernolle, HR Lijnen, ...
Thrombosis research 129 (4), e126-e133, 2012
Mandate: Research Foundation (Flanders)
Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke
A Pedersen, P Redfors, L Lundberg, A Gils, PJ Declerck, S Nilsson, ...
Thrombosis and Haemostasis 116 (09), 537-543, 2016
Mandate: Swedish Research Council
High quality structure of cleaved PAI-1-stab
M Dewilde, SV Strelkov, A Rabijns, PJ Declerck
Journal of structural biology 165 (2), 126-132, 2009
Mandate: Research Foundation (Flanders)
Generation and in vitro characterisation of inhibitory nanobodies towards plasminogen activator inhibitor 1
X Zhou, MLV Hendrickx, G Hassanzadeh-Ghassabeh, S Muyldermans, ...
Thrombosis and haemostasis 116 (12), 1032-1040, 2016
Mandate: Research Foundation (Flanders)
Biopharmaceuticals: reference products and biosimilars to treat inflammatory diseases
A Gils, A Bertolotto, D Mulleman, T Bejan-Angoulvant, PJ Declerck
Therapeutic Drug Monitoring 39 (4), 308-315, 2017
Mandate: Research Foundation (Flanders)
Clearance of plasmin–PN-1 complexes by vascular smooth muscle cells in human aneurysm of the ascending aorta
K Boukais, LF Borges, L Venisse, Z Touat, D François, V Arocas, ...
Cardiovascular Pathology 32, 15-25, 2018
Mandate: National Institute of Health and Medical Research, France
In vitro and in vivo characterisation of the profibrinolytic effect of an inhibitory anti-rat TAFI nanobody
MLV Hendrickx, M Zatloukalova, G Hassanzadeh-Ghassabeh, ...
Thrombosis and haemostasis 112 (05), 824-832, 2014
Mandate: Research Foundation (Flanders)
Advances in understanding pectin methylesterase inhibitor in kiwi fruit: an immunological approach
E Vandevenne, S Christiaens, S Van Buggenhout, RP Jolie, ...
Planta 233, 287-298, 2011
Mandate: Research Foundation (Flanders)
Development and evaluation of monoclonal antibodies as probes to assess the differences between two tomato pectin methylesterase isoenzymes
E Vandevenne, S Van Buggenhout, T Duvetter, E Brouwers, PJ Declerck, ...
Journal of immunological methods 349 (1-2), 18-27, 2009
Mandate: Research Foundation (Flanders)
Species-dependent molecular drug targets in plasminogen activator inhibitor-1 (PAI-1)
A Gils, LM Meissenheimer, G Compernolle, PJ Declerck
Thrombosis and haemostasis 102 (09), 609-610, 2009
Mandate: Research Foundation (Flanders)
DNA-based delivery of anti-DR5 nanobodies improves exposure and anti-tumor efficacy over protein-based administration
G Vermeire, E De Smidt, P Casteels, N Geukens, P Declerck, K Hollevoet
Cancer Gene Therapy 28 (7), 828-838, 2021
Mandate: Research Foundation (Flanders)
Development of an immunological toolbox to detect endogenous and exogenous pectin methylesterase in plant-based food products
E Vandevenne, S Van Buggenhout, M Peeters, G Compernolle, ...
Food research international 44 (4), 931-939, 2011
Mandate: Research Foundation (Flanders)
Glycosylation influences the stability of human plasminogen activator inhibitor-1
B Van De Craen, PJ Declerck, A Gils
Blood Coagulation & Fibrinolysis 23 (6), 570-572, 2012
Mandate: Research Foundation (Flanders)
Immunological toolbox available for in situ exploration of pectic homogalacturonan and its modifying enzymes in fruits and vegetables and their derived food products
E Vandevenne, S Christiaens, S Van Buggenhout, PJ Declerck, ...
Innovative Food Science & Emerging Technologies 15, 72-80, 2012
Mandate: Research Foundation (Flanders)
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt